{"SPADE_UN_00495": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 7078380 B2", "Patent Link": "http://www.lens.org/lens/patent/US_7078380_B2", "Patent Type": "Granted Patent", "Publication Date": "2006-7-18", "Family Info": "CA2426012A1,EP1334117A1,EP1334117B1,US20040106544,WO2002036612A1", "Patent Title": "Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements.", "Abstract": "The invention concerns agents with anti-bacterial activity and methods and intermediates for their production. The present invention further concerns the use of such agents for the treatment of bacterial infections in animals, including man. The agents are derivatives of vancomycin-type antibiotics, of structure: V-L-W-X; wherein V is a glycopeptide moiety which inhibits peptidoglycan biosynthesis in bacteria; L is a linking group; W is a peptidic membrane-associating element such as an element based on naturally-occurring animal or bacterial peptide antibiotics; and X is hydrogen or a membrane-insertive element."}], "Sequence Information": {"SPADE ID": "SPADE_UN_00495", "Peptide Name": "Lin Bac2S-NH2 (linear derivative of bactenecin)", "Source": "Synthetic construct", "Family": "Not found", "Gene": "Not found", "Sequence": "RLSRIVVIRVSR", "Sequence Length": 12, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-"], "Target Organism": "Gram-negative bacteria:Escherichia coli K-12 (MIC=2 µg/ml), Pseudomonas aeruginosa K799 (MIC=16 µg/ml), Salmonella typhimurium 14028s (MIC=32 µg/ml);Gram-positive bacteria:Staphylococcus aureus ATCC 25923 (MIC=4 µg/ml), Staphylococcus epidermidis C621 (MIC=1 µg/ml), Enterococcus faecalis ATCC 29212 (MIC=4 µg/ml), Listeria monocytogenes (MIC=0.25 µg/ml), Corynebacterium xerosis (MIC=0.25 µg/ml), Streptococcus pyogenes ATCC 19615 (MIC=2 µg/ml), S. mitis (MIC=0.125 µg/ml), Streptococcus pneumoniae ATCC 49619 (MIC=16 µg/ml)", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "Not found", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Not found", "Formula": "C63H120N24O15", "Mass": 1453.78, "PI": 12.0, "Net Charge": 4, "Hydrophobicity": 0.48, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "Function": "Has antibacterial activiy against Gram-negative and Gram-positive bacteria.", "Literature": [{"Title": "Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.", "Pubmed ID": "10223951", "Reference": "Antimicrob Agents Chemother. 1999 May;43(5)1274-1276.", "Author": "Wu M, Hancock RE.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=10223951"}], "Frequent Amino Acids": "RVI", "Absent Amino Acids": "ACDEFGHKMNOPQTUWY", "Basic Residues": 4, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 9, "Positive Residues": 4, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_01826", "Similarity": 1.0, "Sequence": "RIVVIRV"}, {"SPADE_ID": "SPADE_UN_01832", "Similarity": 1.0, "Sequence": "RIVVIR"}, {"SPADE_ID": "SPADE_UN_01839", "Similarity": 1.0, "Sequence": "RIVVI"}]}}}